Keywords: usa, clears, fareston, breast, cancer, schering-plough, been

USA Clears Fareston For Breast Cancer

Article | 09 June 1997

Schering-Plough has been granted marketing approval in the USA forFareston (toremifene citrate), a once-daily antiestrogen for the first-line treatment of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Schering Plough

Schering-Plough

Go to company listing

Related Drugs

Fareston

Toremifene

Nolvadex

tamoxifen

Go to drug listing